期刊文献+

滋阴解毒祛瘀法对60例SLE患者生存质量的影响 被引量:5

Effects of Nourishing Yin,Detoxication and Removing Blood Stasis Methods on Survival Quality of SLE Patients
下载PDF
导出
摘要 目的系统评价中医滋阴解毒祛瘀法对系统性红斑狼疮(SLE)生存质量的影响。方法:采用随机、对照、双盲的临床研究设计方案,收集60例肝肾阴虚、热毒血瘀证轻中度活动SLE患者,按随机法分为治疗组和对照组,2组均给予相同西医基础治疗(糖皮质激素+羟氯喹或环磷酰胺),其中治疗组采用滋阴解毒祛瘀方,并根据临床症状随症加减;对照组采用中药安慰剂。结果治疗24周后,随着病情缓解稳定,治疗组、对照组2组患者在躯体功能(PF)、躯体职能(RP)、躯体疼痛(BP)、总体健康(GH)、生命活力(VT)、社交功能(SF)、情感职能(RE)、精神健康(MH)、SF-36总分等方面得分均有所升高。用药24周后,在躯体职能(RP)方面,治疗组(62.50±42.22)分,对照组(37.50±44.30)分,2组组间比较差异有统计学意义(P<0.05);用药24周后,SF-36总积分治疗组(479.21±156.47)分,对照组(415.23±155.61)分,2组组间比较差异有统计学意义(P<0.05)。结论滋阴解毒祛瘀方能提高SLE患者生存质量。 OBJECTIVE To systematically evaluate effects of nourishing yin,detoxication and removing blood stasis methods on survival quality of SLE patients.METHODS Random control and double blind clinical research design was applied in 60cases of liver and kidney yin deficiency,heat toxicity and blood stasis of gentle and moderate movable SLE patients;they were randomly divided into treatment group and control group with both basic western medicine treatment(glucocorticoid+ hydroxychloroquine/cyclophosphane),one of which was also treated by the method of nourishing yin,detoxication and removing blood stasis and the formula was modified according to the symptoms.The control group was also treated by placebo.RESULTS After 24wks treatment,with the gradually relieved symptoms,scores of PF,RP,BP,GH,VT SF,RE,MH SF-36 in both treatment group and control improved.In RP,the treatment group scored(62.50±42.22),control group scored(37.50±44.30),which showed significant differences(P0.05);in SF-36,treatment group scored(479.21±156.47)and control group scored(415.23±155.61),which showed significant differences(P0.05).CONCLUSION Method of nourishing yin,detoxication and removing blood stasis can improve SLE survival quality.
出处 《南京中医药大学学报》 CAS CSCD 北大核心 2012年第5期425-428,共4页 Journal of Nanjing University of Traditional Chinese Medicine
基金 "十一五"国家科技支撑计划(2006BA104A10)
关键词 滋阴解毒祛瘀法 系统性红斑狼疮 临床研究 SF-36 method of nourishing yin detoxication and removing blood stasis SLE clinical study SF-36
  • 相关文献

参考文献13

  • 1朱元珏.评估生命质量逐渐成为临床试验的新标准[J].中华内科杂志,2003,42(11):753-753. 被引量:50
  • 2Simmons RG,Abress L. Quality-cf-life issues for end-stage re- nal diseases patients[J]. Am JKidney Dis, 1990,15(3) :201.
  • 3李鲁,王红妹,沈毅.SF-36健康调查量表中文版的研制及其性能测试[J].中华预防医学杂志,2002,36(2):109-113. 被引量:2222
  • 4任立敏,叶华,赵金霞,潘思思,栗占国.系统性红斑狼疮五年生存率及预后因素分析[J].中华风湿病学杂志,2009,13(3):156-158. 被引量:29
  • 5Wang CC, Mayo NE, Fortin PR. The relationship between healthrelated quality of life and disease activity and damage in systemic lupus erythematosus[J].J Rheumatol, 2001,28 (3) : 525-532.
  • 6Hochberg MC. Updating the American college of Rheumatology revised criteria for the classification of systemic lupus erythema- tosus[J]. Arthritis Rheum,1997,40(9) :508-513.
  • 7.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.346-348.
  • 8Weening JJ, Dagati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematos us revisited[J]. Kidney International, 2004,65 : 521-530.
  • 9World Medical Association Declaration of Helsinki. ethical principles for medical research involving human subject[J]. JAMA,2000,284(23) :3043-3045.
  • 10系统性红斑狼疮诊治指南(草案)[J].中华风湿病学杂志,2003,7(8):508-513. 被引量:215

二级参考文献41

  • 1董光富,叶任高,张晓,石韫珍,崔阳,罗日强.不同免疫抑制方案对狼疮肾炎患者预后的影响[J].中华风湿病学杂志,2004,8(10):604-607. 被引量:7
  • 2陈和年.生存质量测量的方法学研究及其应用[J].中国学术期刊文献,1996,2(7):114-114.
  • 3[3]Bombardies C,Gladman DD,Urowitz,et al.Derivation of the SLEDAI:a disease activity index foe lupus patients[J].Arthritis Rheum,1992,35:630-640
  • 4[5]Ware JE,Shebourne CD.The MOS 36-item short from health survey(SF-36):conceptual framework and item selection[J].Med Care,1992,30:473 -483
  • 5Ware JE Jr, Snow KK, Kosinski M, et al.SF-36 health survey manual and interpretation guide.Boston: New England Medical Center the Health Institute,1993.1-12.
  • 6Perneger TV, Leplege A, Etter JF,et al.Validation of a French-language version of the MOS 36-Item Short Form Health Survey(SF-36) in young healthy adults.J Clin Epidemiol, 1995,48:1051-1060.
  • 7Guillemin F, Bombardier C, Beaton D.Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.J Clin Epidemiol, 1993,46:1417-1432.
  • 8Gandek B, Ware JE Jr.Methods for validating and norming translations of health status questionnaires: the IQOLA Project approach.International Quality of Life Assessment.J Clin Epidemiol, 1998,51:953-959.
  • 9顾杏元,金丕焕.直线回归与相关.见: 金丕焕,主编.医用统计方法.上海:上海医科大学出版社,1993.115-119.
  • 10Lam CL, Gandek B, Ren XS, et al.Tests of scaling assumptions and construct validity of the Chinese(HK) version of the SF-36 Health Survey.J Clin Epidemiol, 1998,51:1139-1147.

共引文献3103

同被引文献55

  • 1李媛丽,王萍,陈维文,姜春燕.系统性红斑狼疮患者生活质量评价及中药干预分析[J].首都医科大学学报,2006,27(6):735-737. 被引量:5
  • 2胡卫东,林昌松,孔德奇,杨浩明,关彤,赵威,郑高坪,陈纪藩.加味桂枝芍药知母汤对类风湿性关节炎患者生存质量干预的研究[J].中国中医药信息杂志,2007,14(4):14-16. 被引量:4
  • 3温成平,范永升,李夏玉,鲁柯达,王新昌.中医解毒祛瘀滋阴法对SLE患者生存质量的影响研究[J].中华中医药学刊,2007,25(8):1599-1602. 被引量:21
  • 4.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.346-348.
  • 5Stewart AL, Ware JE. Measureing functional and weN-being. The Medical Outcomes Study Approach [J]. Durham, N. C. : Duke U- niversity Press, 1992.
  • 6Hochberg MC. Updating the American college of Rheumatology revised criteria for the classification of systemic lupus erythematosus [ J ]. Arthritis Rheum, 1997, 40 (9): 508-513.
  • 7Weening JJ, Dagati VD, Schwartz MM, et al. The classifica- tion of glomerulonephritis in systemic lupus erythematosus us revisited [J].Kidney International, 2004, 65 : 521 - 530.
  • 8张晓忠,张伟杰,刘雪梅.小剂量甲氨蝶吟联合叶酸对老年类风湿关节炎患者炎症因子和免疫功能的影响[J].中华高血压杂志,2015,23(3):281-282.
  • 9Zheng G,Jiang M,He XJ,et al.Discrete derivative:a data slicing algorithm for exploration of sharing biological networks between rheumatoid arthritis and coronary heart disease[J].Bio Data Min,2011,23(4):18-24.
  • 10中华人民共和国卫生部.中药新药临床研究指导原则试行(试行)[M].北京:中国医药科技出版社,2002:349-350.

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部